• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    More On PRAN

    Prana Biotechnology Limited (PRAN)

    -NasdaqCM
    1.33 Down 0.05(3.62%) May 22, 4:00PM EDT
    |After Hours : 1.30 Down 0.03 (2.26%) May 22, 7:06PM EDT
    Add to Portfolio
    Prev Close:1.38
    Open:1.36
    Bid:1.25 x 1000
    Ask:N/A
    1y Target Est:3.00
    Beta:-0.91
    Next Earnings Date:N/A
    Day's Range:1.30 - 1.42
    52wk Range:1.07 - 2.94
    Volume:858,159
    Avg Vol (3m):613,297
    Market Cap:65.03M
    P/E (ttm):N/A
    EPS (ttm):-0.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PRANDown 3.62%65.03M
    JNJDown 1.04%281.05B
    PFEDown 0.23%211.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Prana Biotechnology Limited develops therapies for the treatment of neurodegenerative diseases in Australia. The company focuses on the Alzheimer‘s and Huntington‘s diseases, as well as other age-related degeneration disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback